Publications

  1. Chang AY, Lalia AZ, Jenkins GD, Dutta T, Carter RE, Singh RJ, Nair KS. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism. 2017 Jun; 71:52-63.
    View PubMed
  2. Chang AY, Oshiro J, Ayers C, Auchus RJ. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study. Clin Endocrinol (Oxf). 2016 Jul; 85: (1)92-9.
    View PubMed
  3. Natt N, Chang AY, Berbari EF, Kennel KA, Kearns AE. SELECTION OF ENDOCRINOLOGY SUBSPECIALTY TRAINEES: WHICH APPLICANT CHARACTERISTICS ARE ASSOCIATED WITH PERFORMANCE DURING FELLOWSHIP TRAINING? Endocr Pract. 2016 Jan; 22: (1)45-50.
    View PubMed
  4. Regensteiner JG, Golden S, Huebschmann AG, Barrett-Connor E, Chang AY, Chyun D, Fox CS, Kim C, Mehta N, Reckelhoff JF, Reusch JE, Rexrode KM, Sumner AE, Welty FK, Wenger NK, Anton B, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, and Council on Hypertension. Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation. 2015 Dec 22; 132: (25)2424-47.
    View PubMed
  5. Javed A, Lteif AN, Kumar S, Simmons PS, Chang AY. Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study. J Pediatr Adolesc Gynecol. 2015 Dec; 28: (6)451-6.
    View PubMed
  6. Maroules CD, Chang AY, Kotys-Traughber MS, Peshock RM. Coronary Endothelial Dysfunction in Women With Type 2 Diabetes Measured by Coronary Phase Contrast Flow Velocity Magnetic Resonance Imaging. J Investig Med. 2015 Oct; 63: (7)856-61.
    View PubMed
  7. De Ycaza AE, Chang AY, Jensen JR, Khan Z, Erickson D. Approach to the management of rare clinical presentations of macroprolactinomas in reproductive-aged women. Case Rep Womens Health. 2015 Oct; 8:9-12.
    View PubMed
  8. Guo Q, Erickson BJ, Chang AY, Erickson D. Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy. J Investig Med. 2015 Mar; 63: (3)529-33.
    View PubMed
  9. Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu XS, Smit JW, Jiao J, Yu MK. Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014 Aug; 99: (8)2763-70.
    View PubMed
  10. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT. Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol. 2013 Aug 20; 62(8):752-60. Epub 2013 Apr 16.
    View PubMed
  11. Banks K, Puttagunta D, Murphy S, Lo M, McGuire DK, de Lemos JA, Chang AY, Grundy SM, Khera A. Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study. JACC Cardiovasc Imaging. 2011 Jan; 4(1):65-73.
    View PubMed
  12. Chang AY, Ayers C, Minhajuddin A, Jain T, Nurenberg P, de Lemos JA, Wild RA, Auchus RJ. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin Endocrinol (Oxf). 2011 Jan; 74(1):89-96.
    View PubMed
  13. Maroules CD, Chang AY, Kontak A, Dimitrov I, Kotys M, Peshock RM. Measurement of coronary flow response to cold pressor stress in asymptomatic women with cardiovascular risk factors using spiral velocity-encoded cine MRI at 3 Tesla. Acta Radiol. 2010 May; 51(4):420-6.
    View PubMed
  14. Auchus RJ, Chang AY. 46,XX DSD: the masculinised female. Best Pract Res Clin Endocrinol Metab. 2010 Apr; 24(2):219-42.
    View PubMed
  15. Chang AY, FitzGerald SJ, Cannaday J, Zhang S, Patel A, Palmer MD, Reddy GP, Ordovas KG, Stillman AE, Janowitz W, Radford NB, Roberts AJ, Levine BD. Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players. Am J Cardiol. 2009 Sep 15; 104(6):805-11. Epub 2009 Jul 18.
    View PubMed
  16. Chang AY, Wild RA. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Semin Reprod Med. 2009 Jul; 27(4):299-305. Epub 2009 Jun 15.
    View PubMed
  17. Chang AY, Ghayee HK, Auchus RJ. Dehydroepiandrosterone replacement therapy--panacea, snake oil, or a bit of both? Nat Clin Pract Endocrinol Metab. 2008 Aug; 4(8):442-3. Epub 2008 Jun 17.
    View PubMed
  18. Patel R, Peterson G, Rohatgi A, Ghayee HK, Keeley EC, Auchus RJ, Chang AY. Hyperthyroidism-associated coronary vasospasm with myocardial infarction and subsequent euthyroid angina. Thyroid. 2008 Feb; 18(2):273-6.
    View PubMed
  19. Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH, Lingvay I, Nwariaku FE. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery. 2007 Dec; 142(6):823-8; discussion 828.e1.
    View PubMed
  20. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH, Nwariaku FE. "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients. Surgery. 2007 Dec; 142(6):900-5; discussion 905.e1.
    View PubMed
  21. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007 Jan 2; 49(1):109-16. Epub 2006 Nov 13.
    View PubMed
  22. Chang AY, Schneider JW. Inpatient Evaluation and Management of Congestive Heart Failure. Journal of Clinical Outcomes Management. 2003; 10(4):231-239.
  23. Schneider JW, Chang AY, Garratt A. Trastuzumab cardiotoxicity: Speculations regarding pathophysiology and targets for further study. Semin Oncol. 2002 Jun; 29(3 Suppl 11):22-8.
    View PubMed
  24. Chang AY, McKean SC. History of the Brigham and Women's Hospitalist Service. The Hospitalist. 2002; 6(3):23-25.
  25. Schneider JW, Chang AY, Rocco TP. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart. Semin Oncol. 2001 Oct; 28(5 Suppl 16):18-26.
    View PubMed
  26. Yao X, Chang AY, Boulpaep EL, Segal AS, Desir GV. Molecular cloning of a glibenclamide-sensitive, voltage-gated potassium channel expressed in rabbit kidney. J Clin Invest. 1996 Jun 1; 97(11):2525-33.
    View PubMed